Table 1.
Clinical characteristics of the patients included in this study (n = 31)
| Characteristics | n (%) |
| Patient | |
| Gender (M/F) | 22/9 |
| Age, yr (range) | 47.6 ± 8.8 (28-61) |
| Stage status | |
| III | 18 (58.06) |
| IV | 13 (41.93) |
| Complications | |
| Seroperitoneum | 14 (45.16) |
| Hypoproteinemia | 17 (54.83) |
| Choloplania | 8 (25.80) |
| ECOG performance status | |
| 0 | 3 (9.67) |
| 1 | 18 (58.06) |
| 2 | 10 (32.25) |
| Past history before treatment | |
| Surgery | 4 (12.90) |
| TACE | 7 (22.58) |
| Chemotherapy | 1 (3.22) |
| Surgery + TACE | 8 (25.80) |
| Surgery + chemotherapy | 2 (6.45) |
| TACE + chemotherapy | 3 (9.67) |
| Initial treatment | 6 (19.35) |
M: Male; F: Female; ECOG: Eastern Cooperative Oncology Group; TACE: Transcatheter arterial chemoembolization.